These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 20337920)

  • 1. Pharmacokinetic modeling of doxorubicin pharmacokinetics in dogs deficient in ABCB1 drug transporters.
    Gustafson DL; Thamm DH
    J Vet Intern Med; 2010; 24(3):579-86. PubMed ID: 20337920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxorubicin pharmacokinetics: Macromolecule binding, metabolism, and excretion in the context of a physiologic model.
    Gustafson DL; Rastatter JC; Colombo T; Long ME
    J Pharm Sci; 2002 Jun; 91(6):1488-501. PubMed ID: 12115848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABCB1-1Delta polymorphism can predict hematologic toxicity in dogs treated with vincristine.
    Mealey KL; Fidel J; Gay JM; Impellizeri JA; Clifford CA; Bergman PJ
    J Vet Intern Med; 2008; 22(4):996-1000. PubMed ID: 18537875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incorporation of ABCB1-mediated transport into a physiologically-based pharmacokinetic model of docetaxel in mice.
    Hudachek SF; Gustafson DL
    J Pharmacokinet Pharmacodyn; 2013 Aug; 40(4):437-49. PubMed ID: 23616082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vinblastine pharmacokinetics in mouse, dog, and human in the context of a physiologically based model incorporating tissue-specific drug binding, transport, and metabolism.
    Witta S; Collins KP; Ramirez DA; Mannheimer JD; Wittenburg LA; Gustafson DL
    Pharmacol Res Perspect; 2023 Feb; 11(1):e01052. PubMed ID: 36631976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacokinetics of doxorubicin, etoposide and ifosfamide in small cell lung cancer patients: results of a multicentre study.
    Freyer G; Tranchand B; Ligneau B; Ardiet C; Souquet PJ; Court-Fortune I; Riou R; Rebattu P; Boissel JP; Trillet-Lenoir V; Girard P
    Br J Clin Pharmacol; 2000 Oct; 50(4):315-24. PubMed ID: 11012554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetic screening of CYP3A and ABCB1 in relation to population pharmacokinetics of docetaxel.
    Bosch TM; Huitema AD; Doodeman VD; Jansen R; Witteveen E; Smit WM; Jansen RL; van Herpen CM; Soesan M; Beijnen JH; Schellens JH
    Clin Cancer Res; 2006 Oct; 12(19):5786-93. PubMed ID: 17020985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxorubicin area under the curve is an important predictor of neutropenia in dogs with naturally occurring cancers.
    Wittenburg LA; Weishaar K; Ramirez D; Gustafson DL
    Vet Comp Oncol; 2019 Jun; 17(2):147-154. PubMed ID: 30638304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A physiologically based pharmacokinetic (PBPK) parent-metabolite model of the chemotherapeutic zoptarelin doxorubicin-integration of in vitro results, Phase I and Phase II data and model application for drug-drug interaction potential analysis.
    Hanke N; Teifel M; Moj D; Wojtyniak JG; Britz H; Aicher B; Sindermann H; Ammer N; Lehr T
    Cancer Chemother Pharmacol; 2018 Feb; 81(2):291-304. PubMed ID: 29204687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic evaluation of doxorubicin plasma levels in normal and overweight patients with breast cancer and simulation of dose adjustment by different indexes of body mass.
    Barpe DR; Rosa DD; Froehlich PE
    Eur J Pharm Sci; 2010 Nov; 41(3-4):458-63. PubMed ID: 20688160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ABCB1-1Delta mutation is not responsible for subchronic neurotoxicity seen in dogs of non-collie breeds following macrocyclic lactone treatment for generalized demodicosis.
    Bissonnette S; Paradis M; Daneau I; Silversides DW
    Vet Dermatol; 2009 Feb; 20(1):60-6. PubMed ID: 19152588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Customized in silico population mimics actual population in docetaxel population pharmacokinetic analysis.
    Hudachek SF; Gustafson DL
    J Pharm Sci; 2011 Mar; 100(3):1156-66. PubMed ID: 20803616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral bioavailability of P-glycoprotein substrate drugs do not differ between ABCB1-1Δ and ABCB1 wild type dogs.
    Mealey KL; Waiting D; Raunig DL; Schmidt KR; Nelson FR
    J Vet Pharmacol Ther; 2010 Oct; 33(5):453-60. PubMed ID: 20840389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of potential biomarkers of P-glycoprotein substrate neurotoxicity in transgenic mice expressing the mutated canine ABCB1 gene.
    Zhu M; Ming Y; Swaim H; Swain MD; Myers MJ; Deaver C; Wu X; Jones YL; Yancy HF
    Am J Vet Res; 2014 Dec; 75(12):1104-10. PubMed ID: 25419811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of drug distribution in subcutaneous xenografts of human tumor cell lines and healthy tissues in mouse: application of the tissue composition-based model to antineoplastic drugs.
    Poulin P; Chen YH; Ding X; Gould SE; Hop CE; Messick K; Oeh J; Liederer BM
    J Pharm Sci; 2015 Apr; 104(4):1508-21. PubMed ID: 25615572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic regulation of the ABCB1 gene in drug-sensitive and drug-resistant lymphoid tumour cell lines obtained from canine patients.
    Tomiyasu H; Goto-Koshino Y; Fujino Y; Ohno K; Tsujimoto H
    Vet J; 2014 Jan; 199(1):103-9. PubMed ID: 24332606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the influence of modulation of P-glycoprotein by a multiple dosing regimen of tamoxifen on the pharmacokinetics and toxicodynamics of doxorubicin.
    Darvari R; Boroujerdi M
    Cancer Chemother Pharmacol; 2005 Nov; 56(5):497-509. PubMed ID: 15937726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of doxorubicin in the bladder wall and regional lymph nodes after bladder submucosal injection of liposomal doxorubicin in the dog.
    Kiyokawa H; Igawa Y; Muraishi O; Katsuyama Y; Iizuka K; Nishizawa O
    J Urol; 1999 Feb; 161(2):665-7. PubMed ID: 9915479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanistic pharmacokinetic modeling for the prediction of transporter-mediated disposition in humans from sandwich culture human hepatocyte data.
    Jones HM; Barton HA; Lai Y; Bi YA; Kimoto E; Kempshall S; Tate SC; El-Kattan A; Houston JB; Galetin A; Fenner KS
    Drug Metab Dispos; 2012 May; 40(5):1007-17. PubMed ID: 22344703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Markov Chain Monte Carlo analysis with a physiologically-based pharmacokinetic model of methylmercury to estimate exposures in US women of childbearing age.
    Allen BC; Hack CE; Clewell HJ
    Risk Anal; 2007 Aug; 27(4):947-59. PubMed ID: 17958503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.